Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Jul;38(1):34–50. doi: 10.1038/bjc.1978.161

In vitro evaluation of some derivatives of the carcinogen butter yellow: implications for environmental screening.

J Ashby, J A Styles, D Paton
PMCID: PMC2009672  PMID: 99159

Abstract

The rat-liver carcinogen 4-dimethylaminoazobenzene (Butter Yellow, DAB) and 12 of its structural analogues have been evaluated in a cell transformation assay. Eight of these analogues have already been tested for carcinogenicity in rats, whilst the remaining 4 are new or hitherto untested. Benzidine and its 3,3'-disulphonic acid derivative have also been evaluated. The in vitro results agree with long-term animal data for 8 compounds but disagree in finding DAB-4'-sulphonic acid, 4-trifluoromethyl-DAB and 4-diethylaminoazo-benzene positive. Possible reasons for these divergencies are discussed. It is concluded that 9-phenylazojulolidine and N-methyl-5-phenylazoindoline have carcinogenic potential and that 3,5-dimethyl-4-aminoazobenzene and 4-aminoazobenzene-4'-sulphonic acid are likely to prove non-carcinogenic. Addition of azobenzene to the in vitro assay medium increases the transforming potency of DAB 25-fold. It is suggested that it acts as a competitive substrate for one of the enzymes that detoxify DAB, and that this effect is related to that produced by norharman. Sulphonic-acid derivatives of established carcinogens are usually inactive. The basis of this effect has been investigated, and it is suggested that it can operate by two separate mechanisms. It has been established that this assay cannot be relied upon to predict the in vivo potency of a carcinogen. Consideration has been given to possible changes which could be made to the liver activation system (the S-9 mix) currently used in in vitro carcinogenicity assays, and a diagram is presented of the metabolic conversions of a compound which might lead to mutation or tumour formation. This enables the term potential carcinogen to be accurately defined, and indicates a possible difference between absolute non-carcinogens and compounds which fail to produce cancer in vivo.

Full text

PDF
34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ames B. N., Mccann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975 Dec;31(6):347–364. doi: 10.1016/0165-1161(75)90046-1. [DOI] [PubMed] [Google Scholar]
  3. Ashby J., Purchase I. F. The selection of appropriate chemical class controls for use with short-term tests for potential carcinogenicity. Ann Occup Hyg. 1977 Dec;20(3):297–301. doi: 10.1093/annhyg/20.3.297. [DOI] [PubMed] [Google Scholar]
  4. Ashby J., Styles J. A., Anderson D. Selection of an in vitro carcinogenicity test for derivatives of the carcinogen hexamethylphosphoramide. Br J Cancer. 1977 Nov;36(5):564–571. doi: 10.1038/bjc.1977.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ashby J., Styles J. A. Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature. 1978 Feb 2;271(5644):452–455. doi: 10.1038/271452a0. [DOI] [PubMed] [Google Scholar]
  6. Commoner B., Vithayathil A. J., Henry J. I. Detection of metabolic carcinogen intermediates in urine of carcinogen-fed rats by means of bacterial mutagenesis. Nature. 1974 Jun 28;249(460):850–852. doi: 10.1038/249850a0. [DOI] [PubMed] [Google Scholar]
  7. HADJIOLOV D. C. A histochemical study of succinic dehydrogenase activity in rat liver cancerogenesis induced by 3-methyl-4-dimethylamino-azobenzene. Experientia. 1963 Jun 15;19:316–317. doi: 10.1007/BF02150430. [DOI] [PubMed] [Google Scholar]
  8. Lin J. K., Miller J. A., Miller E. C. Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. Cancer Res. 1975 Mar;35(3):844–850. [PubMed] [Google Scholar]
  9. MILLER J. A., MILLER E. C., FINGER G. C. Further studies on the carcinogenicity of dyes related to 4-dimethylaminoazobenzene; the requirement for an unsubstituted 2-position. Cancer Res. 1957 Jun;17(5):387–398. [PubMed] [Google Scholar]
  10. MILLER J. A., MILLER E. C. The carcinogenic aminoazo dyes. Adv Cancer Res. 1953;1:339–396. doi: 10.1016/s0065-230x(08)60007-x. [DOI] [PubMed] [Google Scholar]
  11. MILLER J. A., SAPP R. W., MILLER E. C. The carcinogenic activities of certain halogen derivatives of 4-dimethylaminoazobenzene in the rat. Cancer Res. 1949 Nov;9(11):652–660. [PubMed] [Google Scholar]
  12. Mainigi K. D., Sorof S. Evidence for a receptor protein of activated carcinogen. Proc Natl Acad Sci U S A. 1977 Jun;74(6):2293–2296. doi: 10.1073/pnas.74.6.2293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Newbold R. F., Wigley C. B., Thompson M. H., Brookes P. Cell-mediated mutagenesis in cultured Chinese hamster cells by carcinogenic polycyclic hydrocarbons: nature and extent of the associated hydrocarbon-DNA reaction. Mutat Res. 1977 Apr;43(1):101–116. doi: 10.1016/0027-5107(77)90136-1. [DOI] [PubMed] [Google Scholar]
  15. Purchase I. F., Longstaff E., Ashby J., Styles J. A., Anderson D., Lefevre P. A., Westwood F. R. An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Br J Cancer. 1978 Jun;37(6):873–903. doi: 10.1038/bjc.1978.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Purchase I. F., Longstaff E., Ashby J., Styles J. A., Anderson D., Lefevre P. A., Westwood F. R. Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use. Nature. 1976 Dec 16;264(5587):624–627. doi: 10.1038/264624a0. [DOI] [PubMed] [Google Scholar]
  17. ROSS W. C., WARWICK G. P. Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system. Nature. 1955 Aug 13;176(4476):298–299. doi: 10.1038/176298a0. [DOI] [PubMed] [Google Scholar]
  18. SPITZ S., MAGUIGAN W. H., DOBRINER K. The carcinogenic action of benzidine. Cancer. 1950 Sep;3(5):789–804. doi: 10.1002/1097-0142(1950)3:5<789::aid-cncr2820030505>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  19. Styles J. A. A method for detecting carcinogenic organic chemicals using mammalian cells in culture. Br J Cancer. 1977 Nov;36(5):558–563. doi: 10.1038/bjc.1977.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. TOPHAM J. C., WESTROP J. W. (THIN-LAYER CHROMATOGRAPHY OF 4-DIMETHYLAMINOAZOBENZENE AND SOME OF ITS METABOLITES.) J Chromatogr. 1964 Oct;16:233–234. doi: 10.1016/s0021-9673(01)82467-5. [DOI] [PubMed] [Google Scholar]
  21. Weisburger J. H., Yamamoto R. S., Williams G. M., Grantham P. H., Matsushima T., Weisburger E. K. On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res. 1972 Mar;32(3):491–500. [PubMed] [Google Scholar]
  22. Yamamoto R. S., Williams G. M., Richardson H. L., Weisburger E. K., Weisburger J. H. Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide. Cancer Res. 1973 Mar;33(3):454–457. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES